DNA methylation-based biomarkers for cardiometabolic-related traits and their importance for risk stratification.
Journal:
Current opinion in epidemiology and public health
Published Date:
Jun 1, 2023
Abstract
RECENT FINDINGS: The prevalence of cardiometabolic syndrome in adults is increasing worldwide, highlighting the importance of biomarkers for individuals' classification based on their health status. Although cardiometabolic risk scores and diagnostic criteria have been developed aggregating adverse health effects of individual conditions on the overall syndrome, none of them has gained unanimous acceptance. Therefore, novel molecular biomarkers have been developed to better understand the risk, onset and progression of both individual conditions and the overall cardiometabolic syndrome.
Authors
Keywords
No keywords available for this article.